High doses of Alzheimer's drug Aricept should be banned, Public Citizen says
Thursday, May 19, 2011 - 15:31
in Health & Medicine
High doses of the Alzheimer's drug Aricept should be banned because they are no more effective than low doses and have a sharply increased risk of adverse effects, the advocacy group Public Citizen and a Johns Hopkins University geriatrician said Wednesday in a petition to the Food and Drug Administration.